PortalPublikationen[Therapy of patients with myeloid leukemia with small doses ...

[Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]

Standard

[Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]. / Patterson, D; Kravtsova, V M; Petrova, E M; Zabelina, Tatjana; Balaian, L N.

in: TERAPEVT ARKH, Jahrgang 59, Nr. 12, 12, 1987, S. 81-86.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Patterson, D, Kravtsova, VM, Petrova, EM, Zabelina, T & Balaian, LN 1987, '[Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]', TERAPEVT ARKH, Jg. 59, Nr. 12, 12, S. 81-86. <http://www.ncbi.nlm.nih.gov/pubmed/3482131?dopt=Citation>

APA

Patterson, D., Kravtsova, V. M., Petrova, E. M., Zabelina, T., & Balaian, L. N. (1987). [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]. TERAPEVT ARKH, 59(12), 81-86. [12]. http://www.ncbi.nlm.nih.gov/pubmed/3482131?dopt=Citation

Vancouver

Patterson D, Kravtsova VM, Petrova EM, Zabelina T, Balaian LN. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]. TERAPEVT ARKH. 1987;59(12):81-86. 12.

Bibtex

@article{25909776dc774fc1b9c24ea9a9ce6f92,
title = "[Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]",
abstract = "A total of 45 patients were given cytosar and daunorubicin therapy at small doses. Of them 23 patients were with acute nonlymphoblastic leukemia, 12--with hemopoietic dysplasia, and 10--with chronic myeloid leukemia. Cytosar was injected subcutaneously every 12 h at a dose of 10 mg/m2 for 10-25 days, daunorubicin was injected intravenously by drop infusion at a dose of 5 mg/m2. Clinicohematological remission was obtained in 13 patients, clinicohematological improvement in 16. Thus, a positive effect was achieved in 29 patients (64%). The authors provided some data on the influence of small doses of cytosar and daunorubicin on cell maturation in vitro.",
author = "D Patterson and Kravtsova, {V M} and Petrova, {E M} and Tatjana Zabelina and Balaian, {L N}",
year = "1987",
language = "Deutsch",
volume = "59",
pages = "81--86",
journal = "TERAPEVT ARKH",
issn = "0040-3660",
publisher = "Izdatel'stvo Meditsina",
number = "12",

}

RIS

TY - JOUR

T1 - [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]

AU - Patterson, D

AU - Kravtsova, V M

AU - Petrova, E M

AU - Zabelina, Tatjana

AU - Balaian, L N

PY - 1987

Y1 - 1987

N2 - A total of 45 patients were given cytosar and daunorubicin therapy at small doses. Of them 23 patients were with acute nonlymphoblastic leukemia, 12--with hemopoietic dysplasia, and 10--with chronic myeloid leukemia. Cytosar was injected subcutaneously every 12 h at a dose of 10 mg/m2 for 10-25 days, daunorubicin was injected intravenously by drop infusion at a dose of 5 mg/m2. Clinicohematological remission was obtained in 13 patients, clinicohematological improvement in 16. Thus, a positive effect was achieved in 29 patients (64%). The authors provided some data on the influence of small doses of cytosar and daunorubicin on cell maturation in vitro.

AB - A total of 45 patients were given cytosar and daunorubicin therapy at small doses. Of them 23 patients were with acute nonlymphoblastic leukemia, 12--with hemopoietic dysplasia, and 10--with chronic myeloid leukemia. Cytosar was injected subcutaneously every 12 h at a dose of 10 mg/m2 for 10-25 days, daunorubicin was injected intravenously by drop infusion at a dose of 5 mg/m2. Clinicohematological remission was obtained in 13 patients, clinicohematological improvement in 16. Thus, a positive effect was achieved in 29 patients (64%). The authors provided some data on the influence of small doses of cytosar and daunorubicin on cell maturation in vitro.

M3 - SCORING: Zeitschriftenaufsatz

VL - 59

SP - 81

EP - 86

JO - TERAPEVT ARKH

JF - TERAPEVT ARKH

SN - 0040-3660

IS - 12

M1 - 12

ER -